CN Patent

CN104379579B — 吡咯烷衍生物及其作为补体途径调节剂的用途

Assigned to Novartis AG · Expires 2017-03-08 · 9y expired

What this patent protects

本发明提供式I化合物：本发明的化合物的制备方法及其作为因子D抑制剂用于治疗眼科疾病的治疗用途。本发明还提供了药理学活性剂的组合和药物组合物。

USPTO Abstract

本发明提供式I化合物：本发明的化合物的制备方法及其作为因子D抑制剂用于治疗眼科疾病的治疗用途。本发明还提供了药理学活性剂的组合和药物组合物。

Drugs covered by this patent

ribociclib-succinate (RIBOCICLIB SUCCINATE)

Patent Metadata

Patent number: CN104379579B
Jurisdiction: CN
Classification: —
Expires: 2017-03-08
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.